mobile-logo

June 2025

16 Jun

New Head of Biometrics and Two Contracts Awarded with New Biometrics Client

by Charmaine Fraser
in Investor News / RNS
Comments

Physiomics plc (AIM: PYC), a leading mathematical modelling, data science and biostatistics company supporting the development of new therapeutics and personalised medicine solutions, is pleased to announce the recruitment of Mr Jesse Thissen as Head of Biometrics, as well as the signing of the Company’s first ever two Biometrics contracts.   Contract Award The two new contracts are with a UK headquartered clinical-stage biopharmaceutical company developing immunotherapies that...

Read More
06 Jun

Dose Matters: Navigating FDA Guidance for Oncology Drug Development – Part 2

by Charmaine Fraser
in Blog
Comments

Part 2 - Modelling a Better Dose: Using MIDD to meet Regulatory Expectations & Make Smarter Decisions in Drug Development     In the previous blog post, we introduced the FDA guidance “Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases”, concepts related to Project Optimus and how these impact different parts of the industry.   This time, we want to dig...

Read More